0001783328-19-000001.txt : 20190726 0001783328-19-000001.hdr.sgml : 20190726 20190726112420 ACCESSION NUMBER: 0001783328-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 EFFECTIVENESS DATE: 20190726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-345133 FILM NUMBER: 19976745 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: (617) 351-2590 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: SUITE 1555 CITY: BOSTON STATE: MA ZIP: 02199 D 1 primary_doc.xml X0708 D LIVE 0001783328 TScan Therapeutics, Inc. 4 Blackfan Circle 8th Floor Boston MA MASSACHUSETTS 02115 (857) 399-9500 DELAWARE T-Scan Therapeutics, Inc. None Corporation true 2018 David Southwell c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Executive Officer Director Lea Hachigian c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Director Steve Kraus c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston ME MAINE 02115 Director Campbell Murray c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Director Hannes Smarason c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Director Timothy Barberich c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Director Christoph Westphal c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Director Robert Crane c/o TScan Therapeutics, Inc. 4 Blackfan Circle, 8th Floor Boston MA MASSACHUSETTS 02115 Executive Officer Biotechnology Decline to Disclose 06b false 2019-07-11 false true false 0 23300000 23300000 0 false 9 0 0 0 false TScan Therapeutics, Inc. /s/ David Southwell David Southwell Chief Executive Officer 2019-07-26